We last reviewed the charts of Perrigo Corp. (PRGO) on April 9, 2020. We wrote that "After dealing with a drug recall fiasco two years ago I cannot wait for drugs and supplements to be made in the U.S. again. I guess I have some skin in the game when I look at PRGO. Traders could approach the long side of PRGO at current levels, risking a close below $41. Our initial upside price target is $56."
More from Stocks
Pull up a chair and let me tell you what drives these insane moves out of industrials and banks in a way that you can understand them and even profit from them.
Universal is a 5% yielding stock and it's growing its payout.
It's the jackals who hound Powell who haven't figured out what's causing inflation.